Why the study?
To evaluate the associations of the triglyceride and glucose index with hypertension stages, phenotypes, and their progressions.
Is a higher Triglyceride and glucose (TyG) index associated with increased risk of hypertension stages, phenotypes, and their progressions in middle-aged and older Chinese adults?
Is a higher Triglyceride and glucose (TyG) index associated with increased risk of hypertension stages, phenotypes, and their progressions in middle-aged and older Chinese adults?
The TyG index is significantly associated with the development and progression of various hypertension stages and phenotypes, suggesting its potential utility as an early indicator for hypertension management.
TyG index may identify higher hypertension risk in middle-aged Chinese adults; leaves open added value for prediction or targeting.
Objectives: To assess the associations of the triglyceride and glucose (TyG) index with hypertension stages, phenotypes, and their progressions. Methods: The data originated from the China Health and Retirement Longitudinal Study. Multinomial logistic regression investigated the associations of the TyG index with hypertension stages (stage 1, stage 2), phenotypes (isolated systolic hypertension [ISH], isolated diastolic hypertension [IDH], systolic diastolic hypertension [SDH]), their progressions. Results: Compared with the lowest quartile of TyG index, the highest quartile was associated with increased risks of stage 1 hypertension (OR 1.71, 95% CI 1.38–2.13), stage 2 (1.74, 1.27–2.38), ISH (1.66, 1.31–2.11), IDH (2.52, 1.26–5.05), and SDH (1.65, 1.23–2.23). Similar results were found when TyG index was a continuous variable. From 2011 to 2015, a higher baseline TyG index was associated with normotension to stage 1 (per-unit: 1.39, 1.16–1.65), normotension to ISH (per-unit: 1.28, 1.04–1.56), and normotension to IDH (per-unit: 1.94, 1.27–2.97). Conclusion: The TyG index was associated with different hypertension stages, phenotypes, their progressions, and could be served as a surrogate indicator for early hypertension management.
No takes yet. Share an insight, caveat, or question.
Shan et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: